Physician profile
Neil Rosenberg
NPI 1265436695
$14,617.81
in general payments reported to CMS, 2019-2025
45 companies · $1,951 in 2025
The $1,951 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,267 · 2020: $1,148 · 2021: $1,772 · 2022: $3,315 · 2023: $2,511 · 2024: $1,654 · 2025: $1,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,115.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,479.40 | 2020-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,397.99 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,415.75 | 2019-2025 | Ofev, Jascayd |
| Verathon INC. | $1,350.00 | 2022 | |
| Genzyme Corporation | $821.44 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $627.42 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $527.61 | 2019-2024 | Yupelri |
| Electromed, INC. | $520.90 | 2019-2025 | Smartvest |
| Inogen, INC. | $517.32 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Grifols USA, LLC | $414.22 | 2019-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $346.05 | 2021-2025 | Glassia |
| Novartis Pharmaceuticals Corporation | $322.92 | 2019-2024 | |
| Genentech USA, INC. | $304.22 | 2019-2023 | Xolair |
| Teva Pharmaceuticals USA, INC. | $287.35 | 2019-2020 | |
| Harmony Biosciences LLC | $259.40 | 2022-2025 | Wakix |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $237.95 | 2021-2025 | Tezspire |
| Inspire Medical Systems, INC. | $210.86 | 2022-2024 | Inspire |
| Philips North America LLC | $195.74 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Medtronic, INC. | $144.02 | 2024 | Sonicision |
| Sunovion Pharmaceuticals INC. | $139.88 | 2019-2020 | |
| Insmed, INC. | $119.31 | 2021-2025 | Arikayce |
| Pfizer INC. | $109.26 | 2019-2025 | |
| Verona Pharma, INC. | $107.32 | 2025 | Ohtuvayre |
| Covis Pharma Gmbh | $88.47 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $86.10 | 2019-2023 | Uptravi, Opsumit |
| United Therapeutics Corporation | $70.18 | 2019-2024 | Tyvaso |
| Watermark Medical, INC. | $47.90 | 2021 | |
| Sanofi-Aventis U.S. LLC | $45.95 | 2022 | |
| Viatris Specialty LLC | $42.16 | 2025 | Yupelri |
| Abbvie INC. | $37.37 | 2022 | |
| Merck Sharp & Dohme LLC | $34.06 | 2021-2023 | |
| Circassia INC. | $31.72 | 2019 | |
| Boston Scientific Corporation | $28.00 | 2022 | |
| Paratek Pharmaceuticals, INC. | $26.50 | 2019 | |
| Baxter Healthcare | $25.64 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Vapotherm INC | $24.32 | 2021 | |
| Jazz Pharmaceuticals INC. | $21.24 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.75 | 2023 | Opsumit |
| La Jolla Pharmaceutical Company | $20.51 | 2023 | Giapreza |
| Tactile Systems Technology INC | $20.02 | 2023 | Entre Plus, Flexitouch Plus |
| Breathe Technologies, INC. | $19.68 | 2019 | |
| Lilly USA, LLC | $19.67 | 2025 | Zepbound |
| Shire North American Group INC | $19.21 | 2019 | |
| Ani Pharmaceuticals, INC. | $18.38 | 2025 | Purified Cortrophin Gel |
| Novo Nordisk INC | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.